1.
AVIAN VIRAL AND BACTERIAL
RESPIRATORY DISEASES
Presented By
Dr. Ahmed Ragab El-Bestawy
BVs, MVs & Ph.D.
Lecturer of Poultry Diseases
Fac. Vet. Med., Damnhour
Univ.
2.
Diseases causing Resp signs:
o Viral:
AI, ND, IB,ILT, TRT, Adeno, Reo, Pox wet form and
MD ( non specific)
o Bacterial:
IC, MG, Ecoli, FC, ORT and Chlamydia.
o Fungal: Asperigellosis.
o Parasitic: Syngamus trachea, Cryptosporidium
o Nutritional: Vit A ↓.
o Miscellaneous: Chilling and Ammonia
4.
Influenza Virus
Family Orthomyxoviridae
Three main types
Type A
Multiple species
Type B
Humans
Type C
Humans and swine
5.
Influenza A
Multiple species
Humans
Avian Influenza
Most virulent group
Classification by surface antigens
into subtypes
Hemagglutinin (H or HA)
Neuraminidase (N or NA)
6.
Surface Antigens
and Subtypes
18 HA and 11 NA for influenza A
Hemagglutinin (HA)
Function: Sites for attachment to infect host cells
Neuraminidase (NA)
Function: Remove neuraminic acid from mucin and
release from cell
8.
Avian Influenza
Pathogenicity based on genetic features and/or
severity of disease
in poultry
Low pathogenic AI (LPAI)
H1 to H18 subtypes
Highly pathogenic AI (HPAI)
Some H5 or H7 subtypes
LPAI H5 or H7 subtypes can mutate
into HPAI
10.
H9 subtype viruses generally exist as low pathogenicity influenza
viruses causing mild to moderate disease. However, they have been
associated with severe morbidity and mortality in poultry as a result
of co-infection with other pathogens.
The first H9N2 influenza virus was isolated from turkeys in Wisconsin
in 1966.
H9N2 subtype influenza viruses were isolated from pigs in Hong Kong
in 1998 and subsequently from two sick children in 1999; six
additional human infections were reported from China
11.
Recent studies have shown that H9N2 viruses may have contributed to
the genetic and geographic diversity of H5N1 viruses.
During the last two decades, antigenic and genetic analysis of H9N2
isolates showed their gradual and complex evolution revealing
extensive re-assortments to generate multiple novel genotypes (7)
with gene segments from different lineages.
12.
Transmission pathways:
Low biosecurity is a high risk.
Market systems
Mainly Air born
13.
Pathogenicity:
Severe morbidity and mortality in poultry results
from:
1. co-infection with other pathogens.
2. Live Vaccines (ND &/or IBV)
3. Management factor.
15.
Clinical signs and PM lesions
Broilers:
Swelling of head.
Respiratory sound.
Decreased feed in take.
Intestinal ballooning.
Pancreatitis
Nephritis
16.
Layers and Breeders:
Depression and slight to moderate decrease
of egg production.
Intestinal twisting and egg peritonitis
Pancreatitis (Thickening of pancrease)
Nephritis
20.
H9N2 vaccines
Inactivated vaccines
Must be Autogenous
Country/regional variation
Vaccine use will:
Prevent clinical signs
Reduce virus shedding
21.
Dose of the vaccine 0.5 ml .
Administration S/C lower back of the neck .
Age of vaccination:
Broiler one Dose at 7-10 day old .
Breeder & layer 1st Dose 10 D.O
2 nd Dose 40 D.O
3 rd Dose 16-18wk .
22.
Currently available H5 vaccine
A. Inactivated homologous vaccine :
B. Inactivated heterologous vaccines:
The vaccine have the same H type as the field but
heterologous neuraminidase.
Clinical protection and reduction in viral shedding are ensured
by the immune reaction caused by H and N used as marker of
field infection.
23.
Dose of the vaccine 0.5 ml .
Administration S/C lower back of the neck .
Age of vaccination:
Broiler one Dose at 7-10 day old .
Breeder & layer 1st Dose 10 D.O
2 nd Dose 40 D.O
3 rd Dose 16-18wk .
24.
Marek‘s with H5
Fowl Pox with H5
Other vectors as ILT or lasota with H5
26.
Mycoplasmas are bacteria that lack cell wall and
belong to the class Mollicutes.
ّهزكجبد الجٌظليي هثل األدّيخ لجؼط هقبّهخ الويكْثالسهب إى
الظلفب.
29.
Major mycoplasma species in poultry
1.M. gallisepticum:
Chronic respiratory disease(CRD in chickens
and infectious sinusitis in turkeys)
embryo mortality, lameness, eye lesions.
2. M. Synoviae:
Infectious tenosynovitis in chickens
Respiratory disease(Turkeys), embryo mortality.
3. M. Meleagridis:
Respiratroy disease, leg weakness, embryo
mortality in turkeys.
4. M. iowae: embryo mortality, leg abnormalities in turkeys.
30.
MYCOPLASMA GALLISEPTICUM INFECTION
Commonly known as chronic respiratory disease (CRD) of
chickens and infection sinusitis in turkeys.
Characterized by respiratory rales, coughing, nasal
discharge, ,conjunctivitis ,growth retardation and drop in
egg production in layers.
31.
ECONOMIC SIGNIFICANCE
1. Increased condemnations (air saculitis) (5-10%)
2. Increased downgrading of carcasses (10-25%)
3. Reduced feed efficiency(5-15%)
4. Reduced egg production (10-20%)& efficiency
5. Increased embryo mortalities (5-20%)
6. Increased mortality rate (5-30%)
7. Increased medication costs
8. Increased costs of prevention and control ,include
surveillance (serology,culture,isolation, and
identification)
33.
Transmission- MG/MS
Vertical (transovarian)
MG/MS are transmitted in eggs laid by infected
breeders
Peak transmission is minimal < 3% of eggs
34.
Horizontal Transmission:
Dust, equipments, wild birds as sparrows,
trucks, feed, workers, vet. doctors, insects
as cats, dogs, contaminated vaccines.
35.
Infected chickens transmit MG/MS
through aerosols (short distances)
contaminated feed and water
MS spreads more rapidly than MG
36.
FEED
Skin: <4 hrs
Ear: 4 hrs
Nose: 1 day
Hair: 3 days
Feathers: 4
days
Feed: 4 hrsRubber: 2
days
Shavings: 8
hrs
Wood: 1 day
Cotton: 4
days
Mechanical transmission and survival of
MG
42.
The latent status, i.e., when the mycoplasma is not
recognized by the host immune system, may be
explained by its intracellular location due to
environmental pressure, as can be exemplified by the
presence of antimicrobials in host tissues for the
treatment of MG, MS or MM infection of birds.
43.
The frequent changes on surface antigens (antigenic
variations due to defective DNA repair system) allow
mycoplasmas to evade the host immune system, and
facilitate their survival when adhered to the host
respiratory tract
44.
Their pathogenic
mechanism for disease include adherence to host target
cells
48.
INCUBATION PERIOD
Varies from 6-21 days
Varies depend on :
MG strain virulence
Complicating infection
Environmental and other stressors
ّالزّهي الذجبج قطؼبى ٔػل األػزاض تظِز هب ًبغبلج
الجيط إًتبج ثذء ػٌذ
49.
1.Coughing
2.Sneezing
3.Gasping
4.Rales
5.Ocular and nasal discharge
6.Decrease in feed consumption
7.Pale comb and head
8.Increased mortalities
Broilers
50.
Mycoplasmosis in Breeders
Reduce egg production (MG free hens laid 15 more eggs
per hen housed than unvaccinated MG infected birds over a
45 week laying period)
lower fertility (MG & MS)
lower egg shell quality
Pipped embryo
poor chick quality
smaller chicks
greater cost per chick
51.
PM lesions
Catarrhal inflammation of sinuses,
trachea, and bronchi.
Air-sacculitis:
54.
Mycoplasma Score 1. No pericarditis and perihepatitis
55.
الهىائية االكياس في تضخم
االكياس في نضح يىجذ ال
االصابة درجة2Dr Lloyd Reeve-Johnson, PhD Thesis, Veterinary Epidemiology
and Economics Research Unit, University of Reading
56.
مع الهىائية االكياس في تضخم
إلتهابية إفرازات و نضح وجىد
الكبذ و القلب على إصابة ال
Dr Lloyd Reeve-Johnson, PhD Thesis, Veterinary Epidemiolo
and Economics Research Unit, University of Reading
درجة3:الهىائية لالكياس شاملة إصابة
60.
Options to assist in eradication
effort or to reduce losses
Medication
Vaccination
61.
Medication
1. Treat MG respiratory diseases
2. Reduce egg production losses
3. Reduce MG shedding and transmission.
4. Reduce severity of lesions and clinical
signs.
5. Significantly reduce population of MG in
the respiratory tract.
Antimycoplasmal drugs have been used
to :
64.
ANTIMYCOPLASMA PLANNING
BROILER
Dose Days
I 1,2,3
II 20,21,22 (With live vaccines
(ND)
65.
Antimycoplasma Planning
Layer-Breeder
Dose Days
I 1,2,3
II For 3 days (20,21,22)
III For 3 days during the 9th week
IV For 3 days during the 17th week
V Feed additive ( premix ) continously
during laying
66.
MG and MS Vaccination
Vaccine types:
MG
F-strain MG
Strain 6/85
TS-11
Bacterin – inactivated
MS
MS-H
MG Bacterin- inactivated
68.
Definition
It’s usually an acute highly contagious
septicemic disease of domestic and wild
birds characterized by respiratory
symptoms accompanied or followed by
nervous manifestation with high losses in
susceptible birds.
(Disease common & serious in Egypt)
69.
Strains of the virus vary in
virulence (Pathogenecity):
a) Velogenic strains: Texas, Herts, highly virulence
used for challenge. Embryo receiving minimal lethal
dose die ( 50hrs ).
b) Mesogenic strains: Komarov, used as a vaccine.
Moderate in pathogencity for CE (2-3 day) for ODO
& 8-10 wks (death rarely).
c) Lentogenic strains: F1, B1, lasota , low virulence
used as a vaccine. Pathogenicity for CE die after
100 hrs. For ODO, 8-10 wks old in apparent disease.
d) Apathogenic: Enteric strains
73.
NP: Nucleoprotein
P: Phosphorilated protein (Overlapping V gene protein)
M: Matrix
F: Fusion with host cell membrane (Smaller spike)
HN: Hemagglutinin / Neuraminidase activities (Largest spike)
L gene: RNA-Directed RNA polimerase (Nucleocapside)
NP P M F0 HN L
Genomic Features
Enveloped pleomorphic RNA virus
100-500 nm size
Single-stranded; Non-segmented
Negative sense (15kb)
Helical nucleocapside symmetry
(Herring-bone like structure)
NDV
Genome
Features
Lentogenic
112RRQRRF117
Velogenic
74.
Although all NDV isolates characterized to date belong to a single
serotype, the avian paramyxovirus serotype 1 (APMV-1), significant
genetic diversity has been recognized among different NDV isolates.
Historically, NDV isolates have been classified into two major groups
(class I and II), based on their genome lengths and the nucleotide
sequences of their genomes.
Class I viruses are distributed worldwide and have been isolated
mainly from waterfowl and shorebirds.
Class II viruses have been divided into 11 genotypes (I to XI) with
genotypes V, VI, VII, and VIII being the predominant genotypes
circulating worldwide.
Among these, genotype VII viruses are particularly important given
that they have been associated with many of the most recent
outbreaks in Asia, Africa, and the Middle East
75.
Antigenicity and immunogenicity
Few antigenic variations
Cell mediated immunity (Local immunity:
mainly IgA )
Humoral immunity
Antibodies against fusion protein
Antibodies against HN protein : HI Ab
Passive immunity of the chick
81.
Kind of ND vaccines used for
immunization of chickens in Egypt:
A. Live lentogenic vaccines: Prepared
from naturally weak strains.
1. F. strain vaccine:
• It is used in chicks aged 1-10 days.
• Via eye dropping , nasal instillation ,
beak dipping
• Local prepared.
82.
Kind of ND vaccines:
2. Hitchiner B1 vaccine:
• Used for individual vaccination (Eye).
• Massive vaccination (D.W) spraying.
• Used in chicks aged 1-10 days.
3. Lasota vaccine:( Colone, Avinew )
• It is more virulent strain than F & B1.
• It must used as a second vaccination
after the first one with either F or B1 .
• It’s used through DW., or spraying.
83.
Kind of ND vaccines:
B. Live mesogenic vaccine:
• As Komarov vaccine, local prepared .
• Administrated only by intermuscular
I/M.
• Used for birds aged not less than 4-6
wks.
• Must be in good healthy condition and
not in production.
84.
Kind of ND vaccines:
C. Inactivated vaccine (Dead vaccine):
• Egg propagated (velogenic virus) killed with
formaline with adjuvant.
• Administ.to chickens & turkeys I/M or S/C.
• Used for vaccination of chickens previously
vaccinated with ND live vaccine.
• It gives immunity after 14 days and the immunity
persist for 3-4 m in birds vaccinated at early age
and for 10-12 m in birds vaccinated at the age of
18-22 wks.
D. Recombonant vaccine :
Its live HVT vaccine Carring F gene of NDV, not
interfere with MDA, apply at 1 DO ,long protect.